Skip to content

Radiology Rewired | Conversations that move radiology forward
Catch up on season 1 before the new season drops

Tune in
  • There are no suggestions because the search field is empty.
  • There are no suggestions because the search field is empty.
Press Release

Dr. Gregory W. Albers Receives the Distinguished Clinical Research Achievement Award

Dr. Albers, Co-Founder of iSchemaView, led the Ground-Breaking DEFUSE 3 Study that Contributed to new American Heart Association and American Stroke Association Guidelines for Thrombectomy

Share to

Dr. Albers, Co-Founder of iSchemaView, led the Ground-Breaking DEFUSE 3 Study that Contributed to new American Heart Association and American Stroke Association Guidelines for Thrombectomy

Washington, D.C. – March 6, 2019 – iSchemaView, the worldwide leader in advanced imaging for stroke care and research, is proud to announce that iSchemaView cofounder Dr. Gregory Albers has received the highly respected Distinguished Clinical Research Achievement Award, presented by the Clinical Research Forum. The Distinguished Clinical Research Achievement Awards are presented to the top two studies that show creativity, innovation, or a novel approach that demonstrates an immediate impact on the health and well-being of patients. In the DEFUSE 3 study, Dr. Albers and his team used iSchemaView’s RAPID™ advanced medical imaging platform, exclusively, to identify stroke patients who continue to have salvageable brain tissue many hours after stroke onset. By identifying patients who are most likely to benefit from stroke therapies, the DEFUSE 3 study is credited with accelerating the development and testing of new therapeutic options, as well as enabling hospitals to offer life-saving stroke therapies to many patients who arrive after the previous standard six-hour treatment window has elapsed. Dr. Albers is the Coyote Foundation professor of neurology and neurological sciences and professor, by courtesy, of neurosurgery at the Stanford University Medical Center. He is also director of the Stanford Stroke Center. Dr. Albers’ primary research focus is the diagnosis, management and prevention of ischemic stroke. He was instrumental in the development of RAPID, a medical imaging platform that allows physicians to identify stroke patients who have salvageable brain tissue. Due to the findings of DEFUSE 3 and other groundbreaking stroke studies that also employed RAPID, the American Heart Association and American Stroke Association changed their treatment guidelines for thrombectomy from six hours after onset to up to 24 hours after onset for patients with salvageable brain tissue. Following the awards ceremony, Dr. Albers will present the results of the DEFUSE 3 study to members of Congress and discuss the critical role of federal funding for clinical research. “My team and I are honored to receive the Distinguished Clinical Research Achievement Award,” said Dr. Albers. “It is incredibly gratifying to know that our findings have helped change the landscape for the diagnosis and treatment of ischemic stroke, leading to more patients being addressed, reducing disabilities and saving lives.” About the Top Ten Clinical Research Achievement Awards Recognizing the need to celebrate our nation's clinical research accomplishments that involve both innovation and impact on human disease, the Clinical Research Forum conducts an annual competition to determine the ten outstanding research accomplishments in the United States. These major research advances represent a portion of the annual return on the nation's investment in the health and future welfare of its citizens. About the Clinical Research Forum The mission of the Clinical Research Forum is to provide leadership to the national and clinical translational research enterprise and promote understanding and support for clinical research and its impact on health and healthcare. For more information, visit www.clinicalresearchforum.org.

Contact PR

Jessica Stebing

Jessica Stebing

Group Manager, Marketing Communications

stebing@rapidai.com

Get to know Rapid in the real world

View All Resources
Video - Lumina Webinar Replay

Webinar

The end of manual head & neck reconstructions // A faster path with Lumina 3D

In this webinar, we focus on the challenges and opportunities in 3D head and neck CTA reconstruction workflows. Our speakers share real-world insights on how the Lumina 3D platform can have a tangible impact on CT workflow, scanner throughput, and diagnosis.
Radiology Rewired Podcast - Episode 1 Thumbnail

Podcast

AI Meets Imaging | Radiology Rewired | Ep. 1

In the debut episode of Radiology Rewired, RapidAI’s new clinician-led podcast hosted by Dr. Singh, Dr. Greg Albers—founder of RapidAI and professor of neurology at Stanford University—shares the story behind one of medicine’s most important breakthroughs: extending the stroke treatment window to 24 hours. Dr. Albers recounts how decades of imaging research led from early diffusion-perfusion MRI to automated AI tools that changed global stroke guidelines and transformed how teams diagnose and treat patients. This episode explores how deep clinical AI is reshaping radiology and why credible, clinician-led innovation remains essential for the next generation of healthcare technology.
Resources - multistakeholder white paper

White paper

The clinical AI champion's guide: getting to "yes" in complex health systems

This guide is designed for internal champions, clinicians, service line leaders, and administrators who believe in the potential of AI to improve care and operations. It offers practical insights from a C-suite advisory panel from leading health systems across the nation on how decisions are made, who typically drives them forward, and what tools and strategies are proving most effective in securing alignment and buy-in across the system.